Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): The BioMe Biobank at Mount Sinai

ABSTRACT: NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): The BioMe Biobank at Mount Sinai

PROVIDER: PRJNA326148 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): The BioMe Biobank at Mount Sinai

Project description:NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): The BioMe Biobank at Mount Sinai

| PRJNA478091 | ENA

NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): The BioMe Biobank at Mount Sinai

Project description:NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): The BioMe Biobank at Mount Sinai

| PRJNA478092 | ENA

Homo sapiens

Project description:NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): The BioMe Biobank at Mount Sinai

| PRJNA326149 | ENA

PAGE: IPM BioMe Biobank

Project description:The Institute for Personalized Medicine (IPM) BioMe Biobank is a consented, EMR-linked medical care setting biorepository of the Mount Sinai Medical Center (MSMC) drawing from a population of over 70,000 inpatients and 800,000 outpatient visits annually. MSMC serves diverse local communities of upper Manhattan, including Central Harlem (86% African American), East Harlem (88% Hispanic Latino), and Upper East Side (88% Caucasian/white) with broad health disparities. IPM BioMe Biobank populations include 28% African American, 38% Hispanic Latino predominantly of Caribbean origin, 23% Caucasian/White. IPM BioMe Biobank disease burden is reflective of health disparities with broad public health impact. Biobank operations are fully integrated in clinical care processes, including direct recruitment from clinical sites waiting areas and phlebotomy stations by dedicated Biobank recruiters independent of clinical care providers, prior to or following a clinician standard of care visit. Recruitment currently occurs at a broad spectrum of over 30 clinical care sites. This study is part of the Population Architecture using Genomics and Epidemiology (PAGE) study (<a href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000356.v1.p1">phs000356</a>).

| phs000925 | dbGaP

BioMe Biobank Program T2D-GENES Exome Sequencing Study

Project description:BioMe Biobank Program T2D-GENES Exome Sequencing Study

| PRJNA427042 | ENA

BioMe Biobank Program T2D-GENES Exome Sequencing Study

Project description:BioMe Biobank Program T2D-GENES Exome Sequencing Study

| PRJNA420610 | ENA

PAGE: The Charles Bronfman Institute for Personalized Medicine (IPM) BioMe Biobank

Project description:PAGE: The Charles Bronfman Institute for Personalized Medicine (IPM) BioMe Biobank

| PRJNA285518 | ENA

NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study

Project description:NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study

| PRJNA434035 | ENA

NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study

Project description:NHLBI TOPMed - Centers for Common Disease Genomics (CCDG): Atrial Fibrillation Biobank Ludwig Maximilian University (AFLMU) Study

| PRJNA434036 | ENA

A functional genomics predictive network model identifies regulators of inflammatory bowel disease: Mount Sinai Hospital (MSH) Population Specimen Collection and Profiling of Inflammatory Bowel Disease

Project description:This study focuses on inflammatory bowel disease gene expression profiling. Surgical specimens from 134 patients undergoing bowel resection for inflammatory bowel disease (IBD) and non IBD controls at Mount Sinai Medical Center were collected as the source of tissue. Control samples (CLs) were harvested from normal non inflamed bowel located more than 10 cm away from the tumor from patients undergoing bowel resection for sporadic colon cancer. Ulcerative colitis (UC) and Crohn’s (CD) patient samples were all isolated from areas containing moderate to severe inflammation. The diagnostic pathology report for each specimen was provided by the Mount Sinai Hospital Pathology Department. Patients with UC and patients with CD shared common medications including corticosteroids, infliximab, azathioprine, and mesalamine.

2017-07-07 | GSE83687 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data